Mergers and Acquisitions

Tribune Publishing on Monday rejected a sweetened takeover offer from Gannett, insisting its turnaround plan is better than Gannett's bid, and said a billionaire entrepreneur would take a $70 million stake in the company.

After weeks of wrangling the two are near a deal to create a global seed giant.

Quarrels have broken out behind the scenes and that could spell trouble for the landmark healthcare deal, according to the WSJ.

A top investor in German chemicals company Bayer has said on Friday he was "furious" at the company's refusal to engage with him over its recent bid for U.S. rival Monsanto.

Gannett, the publisher of USA Today, raised its all-cash offer to buy Tribune Publishing to $15 per share from $12.25, valuing the publisher of the Chicago Tribune and the Los Angeles Times at about $864 million

Pfizer will buy Anacor Pharmaceuticals in a deal valued at $5.2 billion, net of cash, for access to Anacor's non-steroidal topical gel to treat eczema.

Gannett, the publisher of USA Today, raised its all-cash offer to buy Tribune Publishing Co to $15 per share from $12.25

Oil and gas producer Range Resources said it would buy Memorial Resource Development in an all-stock deal valued at $4.4 billion, including $1.1 billion in debt.

Berkshire Hathaway Chairman Warren Buffett is reportedly backing a consortium vying for Yahoo's nternet assets that includes Quicken Loans founder.

Big M&A is facing an economic-buzz saw from the White House.

Baker Hughes and Halliburto, two of the nation’s biggest oilfield services companies, announced they terminated their highly-contested merger deal after regulators in both the U.S. and Europe declined to give the tie up a green light.

Oilfield services provider Halliburton and smaller rival Baker Hughes announced the termination of their $28 billion merger deal on Sunday after opposition from U.S. and European antitrust regulators.

Comcast Corp, the owner of NBCUniversal, said on Thursday it would buy DreamWorks Animation SKG Inc for $3.8 billion in cash.

Abbott Laboratories said it agreed to buy medical device maker St. Jude Medical for $25 billion to add heft to its heart and neurological devices business.

French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover fight after the U.S. cancer firm rebuffed its approaches.

Fiat Chrysler CEO Sergio Marchionne believes his campaign to seek out a merger partner has been “worth the effort,” saying one of the company’s rivals will likely answer the call--eventually.